Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1984, Review of mortality results in randomised trials in early breast cancer, Lancet, 2, 1205

1988, Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28 896 women, N Engl J Med, 319, 1681, 10.1056/NEJM198812293192601

1990

1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women, Lancet, 339, 1

1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women, Lancet, 339, 71, 10.1016/0140-6736(92)90997-H

1995, Effects of radiotherapy and surgery in early breast cancer: an overview of the randomised trials, N Engl J Med, 333, 1444, 10.1056/NEJM199511303332202

1996, Ovarian ablation in early breast cancer: overview of the randomised trials, Lancet, 348, 1189, 10.1016/S0140-6736(96)05023-4

1998, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4

1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7

2000, Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials, Lancet, 355, 1757, 10.1016/S0140-6736(00)02263-7

Peto, 1977, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, part II: analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1

Collins, 2003, Large-scale randomised evidence: trials and overviews, 24

Albain, 2004, Concurrent versus sequential chemohormonal therapy for postmenopausal receptor-positive breast cancer: mature outcomes and new biologic correlates in phase III intergroup trial 0100, Breast Cancer Res Treat, 88

1996, Randomised trial of 2 versus 5 years of adjuvant tamoxifen in postmenopausal early-stage breast cancer, J Natl Cancer Inst, 88, 1543, 10.1093/jnci/88.21.1543

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371

Walsh, 2001, The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors, Ann New York Acad Sci, 949, 163, 10.1111/j.1749-6632.2001.tb04015.x

Gray, 2000, Tamoxifen for early breast cancer: better late then never, Ann Oncol, 11, 505, 10.1023/A:1008323116265

Cocconi, 2003, Adjuvant chemotherapy in early breast cancer: optimal and suboptimal anthracycline-containing regimens, Breast Cancer Res Treat, 80, 313, 10.1023/A:1024955408785

Mariotto, 2002, Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States, 1979–1999, J Natl Cancer Inst, 94, 1626, 10.1093/jnci/94.21.1626

Peto, 2000, UK and USA breast cancer deaths down 25% in 2000 at ages 20–69 years, Lancet, 355, 1822, 10.1016/S0140-6736(00)02277-7